Phellodendron and Citrus extracts benefit cardiovascular health in osteoarthritis patients: a double-blind, placebo-controlled pilot study.

Oben J, Enonchong E, Kothari S, Chambliss W, Garrison R, Dolnick D.

Nutr J. 2008 May 20;7:16.

PMID: 18492265 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.

Garrison R, Chambliss WG.

Altern Ther Health Med. 2006 Jan-Feb;12(1):50-4.

PMID: 16454147 [PubMed - indexed for MEDLINE]

Related Articles

Efficacy of 12 weeks supplementation of a botanical extract-based weight loss formula on body weight, body composition and blood chemistry in healthy, overweight subjects--a randomised double-blind placebo-controlled clinical trial.

Opala T, Rzymski P, Pischel I, Wilczak M, Wozniak J.

Eur J Med Res. 2006 Aug 30;11(8):343-50.

PMID: 17052970 [PubMed - indexed for MEDLINE]

Related Articles

Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial.

Anderson JW, Schwartz SM, Hauptman J, Boldrin M, Rossi M, Bansal V, Hale CA.

Ann Pharmacother. 2006 Oct;40(10):1717-23. Epub 2006 Aug 29.

PMID: 16940406 [PubMed - indexed for MEDLINE]

Related Articles

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.

Diabetes Obes Metab. 2000 Apr;2(2):105-12.

PMID: 11220522 [PubMed - indexed for MEDLINE]

Related Articles

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J; RIO-North America Study Group.

JAMA. 2006 Feb 15;295(7):761-75. Erratum in: JAMA. 2006 Mar 15;295(11):1252.

PMID: 16478899 [PubMed - indexed for MEDLINE]

Related Articles

Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial.

Kalman DS, Feldman S, Feldman R, Schwartz HI, Krieger DR, Garrison R.

Nutr J. 2008 Apr 21;7:11.

PMID: 18426577 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

Diabetes Obes Metab. 2003 May;5(3):180-8.

PMID: 12681025 [PubMed - indexed for MEDLINE]

Related Articles

Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial.

Salas-Salvadó J, Farrés X, Luque X, Narejos S, Borrell M, Basora J, Anguera A, Torres F, Bulló M, Balanza R; Fiber in Obesity-Study Group.

Br J Nutr. 2008 Jun;99(6):1380-7. Epub 2007 Nov 22.

PMID: 18031592 [PubMed - indexed for MEDLINE]

Related Articles

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.

Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL.

Clin Ther. 2007 Jan;29(1):74-83.

PMID: 17379048 [PubMed - indexed for MEDLINE]

Related Articles

Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.

Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, Stohs SJ, Stern JS, Keen CL.

Int J Obes (Lond). 2006 Oct;30(10):1545-56. Epub 2006 Mar 21.

PMID: 16552410 [PubMed - indexed for MEDLINE]

Related Articles

Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.

Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.

Clin Ther. 2004 Sep;26(9):1427-35.

PMID: 15531005 [PubMed - indexed for MEDLINE]

Related Articles

The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.

Muls E, Kolanowski J, Scheen A, Van Gaal L; ObelHyx Study Group.

Int J Obes Relat Metab Disord. 2001 Nov;25(11):1713-21.

PMID: 11753595 [PubMed - indexed for MEDLINE]

Related Articles

One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.

Finer N, James WP, Kopelman PG, Lean ME, Williams G.

Int J Obes Relat Metab Disord. 2000 Mar;24(3):306-13.

PMID: 10757623 [PubMed - indexed for MEDLINE]

Related Articles

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P.

Diabetes Care. 2002 Jun;25(6):1033-41. Erratum in: Diabetes Care. 2003 Mar;26(3):971..

PMID: 12032111 [PubMed - indexed for MEDLINE]

Related Articles

Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.

Chow CC, Ko GT, Tsang LW, Yeung VT, Chan JC, Cockram CS.

Diabetes Care. 1997 Jul;20(7):1122-7.

PMID: 9203448 [PubMed - indexed for MEDLINE]

Related Articles

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

Diabetes Obes Metab. 2000 Jun;2(3):175-87.

PMID: 11220553 [PubMed - indexed for MEDLINE]

Related Articles

Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus.

Hollander P.

Am J Med. 2007 Feb;120(2 Suppl 1):S18-28; discussion S29-32.

PMID: 17296341 [PubMed - indexed for MEDLINE]

Related Articles

Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.

Derosa G, Cicero AF, D'Angelo A, Ragonesi PD, Ciccarelli L, Fogari E, Salvadeo SA, Ferrari I, Gravina A, Fassi R, Fogari R.

Clin Drug Investig. 2006;26(9):529-39.

PMID: 17163286 [PubMed - indexed for MEDLINE]

Related Articles

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.

Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, Heimburger DC, Lucas CP, Robbins DC, Chung J, Heymsfield SB.

JAMA. 1999 Jan 20;281(3):235-42. Erratum in: JAMA 1999 Apr 7;281(13):1174.

PMID: 9918478 [PubMed - indexed for MEDLINE]

Related Articles